Emisphere Technologies (EMIS) News Today $7.81 0.00 (0.00%) As of 12/9/2020 Add Compare Share Share Headlines Stock AnalysisBuy This Stock EMIS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Earnings call: SWK Holdings focuses on life science finance growthMay 18, 2024 | au.investing.comExco Technologies Limited (XTC.TO)March 3, 2024 | ca.finance.yahoo.comInsulin pill could free diabetics from jabsDecember 11, 2023 | dailymail.co.ukSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the FirmNovember 19, 2023 | barrons.comEMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Emisphere Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 23, 2023 | businesswire.comEntwistle & Cappucci LLP Files a Securities Class Action Complaint Against Emisphere Technologies, Inc.October 5, 2023 | benzinga.comBuccal Drug Delivery System Global Market Report 2023May 8, 2023 | finance.yahoo.comFlying high on obesity success, Novo's appetite for deals growsMay 4, 2023 | msn.comInformative Market Research Report on Thrombin Inhibitor with Estimated CAGR of 12.5% from 2023-2030April 16, 2023 | marketwatch.comOral Biologics & Biosimilars Global Market Report 2023April 11, 2023 | uk.finance.yahoo.comIncretin-Based Drugs Market Size Regional Analysis 2023 which includes Rapid Growth Rate Till 2025March 2, 2023 | marketwatch.comGlobal Non-insulin Diabetes Therapeutics Market Size Analysis, Share, Application, Opportunities Forecast to 2030 By VMReportsFebruary 19, 2023 | marketwatch.comInsulin Detemir Market 2023 Size, Share, Applications, Advance Technology And Top Companies To 2026February 14, 2023 | marketwatch.comOral Biologics & Biosimilars Global Market Report 2022September 23, 2022 | benzinga.comDiabetes Devices Market Size is projected to reach USD 49.25 Billion by 2030, growing at a CAGR of 6.62%: Straits ResearchJuly 20, 2022 | benzinga.comOral Drug Delivery Market Analysis, Key Players, Segmentation, Application And rate of 7.60% in the forecast period of 2022 to 2029March 10, 2022 | marketwatch.comEmisphere Tech (EMIS)February 24, 2022 | za.investing.comEmisphere Technologies, Inc.(EMIS)February 22, 2022 | fool.comHealth Stocks in MotionJanuary 17, 2022 | thestreet.comLaw360 Pulse's Spotlight On Mid-Law WorkDecember 19, 2021 | law360.comFormer NFL Quarterback, MLB Pitcher Chad Hutchinson is Now a Sports PE ExecutiveNovember 18, 2021 | bloomberg.com3 Firms Lead Novo Nordisk's $3.3B Dicerna BuyNovember 18, 2021 | law360.comNovo Nordisk's New Obesity Drug Boosted 3Q Earnings -- Earnings ReviewNovember 4, 2021 | marketwatch.comCounsel In $1.8B Biotech Sale Suit Urged To Work TogetherOctober 15, 2021 | law360.comThrombin Inhibitors Market Trends, Size, Market Share, Growth Factor, Opportunities, Segment, Top Manufacturers, Drivers and Forecast 2021-2026September 23, 2021 | marketwatch.comLead Counsel Battle Heats Up In $1.8B Biotech Sale SuitSeptember 7, 2021 | law360.comAccomplished Industry Executive Alan L. Rubino Named Chairman of AMO Pharma Board of DirectorsAugust 19, 2021 | morningstar.comMRobbins, Friedlander Seek To Lead $1.8B Biotech Sale SuitAugust 17, 2021 | law360.com Get Emisphere Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for EMIS and its competitors with MarketBeat's FREE daily newsletter. Email Address EMIS Media Mentions By Week EMIS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EMIS News Sentiment▼0.000.48▲Average Medical News Sentiment EMIS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EMIS Articles This Week▼00▲EMIS Articles Average Week Get Emisphere Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for EMIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Astellas Pharma News MEI Pharma News Recordati Industria Chimica E Farmaceutica News Silence Therapeutics News UCB News Chugai Pharmaceutical News Zoetis News Daiichi Sankyo News Takeda Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EMIS) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emisphere Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emisphere Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
